A Pilot Study of the Safety and Immunogenicity of Folate Receptor Alpha Peptide-Loaded Dendritic Cell Vaccination in Patients With Advanced Stage Epithelial Ovarian Cancer
Phase of Trial: Phase II
Latest Information Update: 23 May 2017
At a glance
- Drugs TPIV 200 (Primary)
- Indications Adenocarcinoma; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 07 Jun 2017 Biomarkers information updated
- 23 May 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Sep 2017.
- 13 Jun 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Apr 2017.